Paricalcitol Capsule for the Treatment of Secondary Hyperparathyroidism in Stages 3 and 4 CKD
- 1 February 2006
- journal article
- research article
- Published by Elsevier BV in American Journal of Kidney Diseases
- Vol. 47 (2), 263-276
- https://doi.org/10.1053/j.ajkd.2005.10.007
Abstract
No abstract availableKeywords
This publication has 31 references indexed in Scilit:
- Vitamin D Insufficiency and Deficiency in Chronic Kidney DiseaseAmerican Journal of Nephrology, 2004
- Mineral Metabolism, Mortality, and Morbidity in Maintenance HemodialysisJournal of the American Society of Nephrology, 2004
- The Severity of Secondary Hyperparathyroidism in Chronic Renal Insufficiency is GFR-Dependent, Race-Dependent, and Associated with Cardiovascular DiseaseJournal of the American Society of Nephrology, 2002
- Renal Osteodystrophy in Chronic Renal FailureSeminars in Nephrology, 2002
- Association of Elevated Serum PO4, Ca × PO4 Product, and Parathyroid Hormone with Cardiac Mortality Risk in Chronic Hemodialysis PatientsJournal of the American Society of Nephrology, 2001
- Pathogenesis of secondary hyperparathyroidismKidney International, 1999
- Phosphorus, Regulation of Plasma Calcium, and Secondary HyperparathyroidismJournal of the American Society of Nephrology, 1999
- Bone disease in predialysis, hemodialysis, and CAPD patients: Evidence of a better bone response to PTHKidney International, 1995
- Correlation of bone histology with parathyroid hormone, vitamin D3, and radiology in end-stage renal diseaseKidney International, 1993
- Bone histology in incipient and advanced renal failureKidney International, 1976